TNFSF11 and neoplasm: Therefore, we propose to improve the translational potential of our RANKL imaging agent by developing a lower-molecular weight radiolabeled antibody fragment (Fab)—[64Cu]Cu-NOTA-denos-Fab—which has intrinsic shorter circulation times, uses short half-lived radiometals, and combines fast renal clearance with improved distribution throughout the tumor [23].